Abstract
Prior research has indicated that the gut-lung-axis can be influenced by the intestinal microbiota, thereby impacting lung immunity. Rifaximin is a broad-s
Funding Information
  • National Natural Science Foundation of China (32272992)
  • Xinjiang Animal Disease Prevention and Control Engineering Technology Research Center (GC2021003)